help button home button Am J Pathol International Conference on Pathology of Chest Diseases
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tanner, M. M.
Right arrow Articles by Isola, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tanner, M. M.
Right arrow Articles by Isola, J. J.
(American Journal of Pathology. 1998;153:191-199.)
© 1998 American Society for Investigative Pathology

Regular Articles

Genetic Aberrations in Hypodiploid Breast Cancer

Frequent Loss of Chromosome 4 and Amplification of CyclinD1 Oncogene

Minna M. Tanner* , Ritva A. Karhu* , Nina N. Nupponen* , Åke Borg{dagger} , Bo Baldetorp{dagger} , Tanja Pejovic{dagger} , Mårten Fernö{dagger} , Dick Killander{dagger} and Jorma J. Isola*

From the Laboratory of Cancer Genetics,* University and University Hospital of Tampere, Tampere, Finland, and the Department of Oncology,{dagger} University of Lund, Lund, Sweden

The evolution of somatic genetic aberrations in breast cancer has remained poorly understood. The most common chromosomal abnormality is hyperdiploidy, which is thought to arise via a transient hypodiploid state. However, hypodiploidy persists in 1 to 2% of breast tumors, which are characterized by a poor prognosis. We studied the genetic aberrations in 15 flow cytometrically hypodiploid breast cancers by comparative genomic hybridization (CGH) and fluorescence in situ hybridization (FISH). Surprisingly, numerous copy number gains were detected in addition to the copy number losses. The number of gains per tumor was 4.3 ± 3.2 and that of losses was 4.5 ± 3.3 (mean ± SD), which is similar to that previously observed in hyperdiploid breast cancers. Gains at chromosomes or chromosomal regions at 11q13, 1q, 19, and 16p and losses of 2q, 4, 6q, 9p, 13, and 18 were most commonly observed. Compared with unselected breast carcinomas, hypodiploid tumors showed certain differences. Loss of chromosome 4 (53%) and gain of 11q13 (60%) were significantly more common in hypodiploid tumors. The gain at 11q13 was found by FISH to harbor amplification of the Cyclin D1 oncogene, which is therefore three to four times more common in hypodiploid than in unselected breast cancers (15 to 20%). Structural chromosomal aberrations (such as Cyclin D1 amplification) were present both in diploid and hypodiploid tumor cell populations, as assessed by FISH and CGH after flow cytometric sorting. Together these results indicate that hypodiploid tumors form a distinct genetic entity of invasive breast cancer, although they probably share a common genetic evolution pathway where structural chromosomal aberrations precede gross DNA ploidy changes.




This article has been cited by other articles:


Home page
 J. Clin. Pathol.Home page
A E Pinto, L Roque, R Rodrigues, S Andre, and J Soares
Frequent 7q gains in flow cytometric multiploid/hypertetraploid breast carcinomas: a study of chromosome imbalances by comparative genomic hybridisation
J. Clin. Pathol., April 1, 2006; 59(4): 367 - 372.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K. J. Reichenberger, R. D. Coletta, A. P. Schulte, M. Varella-Garcia, and H. L. Ford
Gene Amplification Is a Mechanism of Six1 Overexpression in Breast Cancer
Cancer Res., April 1, 2005; 65(7): 2668 - 2675.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Staff, J. Isola, and M. Tanner
Haplo-insufficiency of BRCA1 in Sporadic Breast Cancer
Cancer Res., August 15, 2003; 63(16): 4978 - 4983.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
G. L. Firestone and L. F. Bjeldanes
Indole-3-Carbinol and 3-3'-Diindolylmethane Antiproliferative Signaling Pathways Control Cell-Cycle Gene Transcription in Human Breast Cancer Cells by Regulating Promoter-Sp1 Transcription Factor Interactions
J. Nutr., July 1, 2003; 133(7): 2448S - 2455.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
G. P. Risbridger, J. F. Schmitt, and D. M. Robertson
Activins and Inhibins in Endocrine and Other Tumors
Endocr. Rev., December 1, 2001; 22(6): 836 - 858.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K. Rennstam, B. Baldetorp, S. Kytölä, M. Tanner, and J. Isola
Chromosomal Rearrangements and Oncogene Amplification Precede Aneuploidization in the Genetic Evolution of Breast Cancer
Cancer Res., February 1, 2001; 61(3): 1214 - 1219.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
F. Forozan, E. H. Mahlamäki, O. Monni, Y. Chen, R. Veldman, Y. Jiang, G. C. Gooden, S. P. Ethier, A. Kallioniemi, and O.-P. Kallioniemi
Comparative Genomic Hybridization Analysis of 38 Breast Cancer Cell Lines: A Basis for Interpreting Complementary DNA Microarray Data
Cancer Res., August 1, 2000; 60(16): 4519 - 4525.
[Abstract] [Full Text]

Home page
 Am. J. Pathol.Home page
S. Knuutila, Y. Aalto, K. Autio, A.-M. Bjorkqvist, W.'e. El-Rifai, S. Hemmer, T. Huhta, E. Kettunen, S. Kiuru-Kuhlefelt, M. L. Larramendy, et al.
DNA Copy Number Losses in Human Neoplasms
Am. J. Pathol., September 1, 1999; 155(3): 683 - 694.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
E. J. Cram, B. D. Liu, L. F. Bjeldanes, and G. L. Firestone
Indole-3-carbinol Inhibits CDK6 Expression in Human MCF-7 Breast Cancer Cells by Disrupting Sp1 Transcription Factor Interactions with a Composite Element in the CDK6 Gene Promoter
J. Biol. Chem., June 15, 2001; 276(25): 22332 - 22340.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by the American Society for Investigative Pathology.